|
Recent Developments |
|
18-JUN-12
Astec Lifesciences today announced the commencement of commercial production at its new state of the art manufacturing facility at its new site in MIDC at Mahad.
01-FEB-12
Astec Lifesciences has announced that the company has entered into an exclusive long term contract with a multinational company to manufacture and supply a fungicide.
01-DEC-10
Astec Lifesciences announced that it has formed a 100% subsidiary company namely Astec... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 30-Sep-2017(6) | 31-Mar-2017 (12) | 31-Mar-2016(12) | | Net sales | 1682.00 | 3127.57 | 2446.34 | | Other Income | 46.39 | 23.74 | 0.00 | | Total Income | 1728.39 | 3151.31 | 2446.34 | | Cost of goods sold | 1532.83 | 2622.29 | 2253.46 | | OPBDIT | 195.56 | 529.02 | 192.88 | | PAT | 106.90 | 190.94 | -203.49 | | Gross Block | - | - | - | | Equity capital | - | 0.00 | 194.55 | | EPS (Rs.) | - | 0.00 | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | NA | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 11.3 | 16.8 | 7.9 | | Net margin (% of OI) | 6.2 | 6.1 | -8.3 |
|
|
Detailed Financials
|
|
|
|
|
